Qualcomm v. Arm: The Jury Returns Tuesday — and the Clause Ruling Matters More to Arm Than to Qualcomm
The Delaware trial this market has tracked for weeks (see prior revisions for the trial calendar and the Huawei cross-license) reached its decision point Friday — and blinked. Per Reuters (Oct 9): "The jury in a lawsuit by chipmaker Qualcomm against chip technology supplier Arm Holdings did not reach a verdict on Friday as to whether Arm breached licensing agreements and intentionally sabotaged some of Qualcomm's dealings with Meta Platforms... After deliberating for about four hours Friday, the jury had not reached a verdict, indicating it would return to deliberations on Tuesday." Tuesday is Oct 13 — tomorrow.
What's actually being decided. Per TIKR's case breakdown: Qualcomm claims "Arm withheld software patches and design tools it owed under contract," broke a promise that Qualcomm pay within 10% of the lowest price for Arm's processor designs, and "leaked its 2024 threat to cancel Qualcomm's license, hurting talks over a chip deal with Meta Platforms." The load-bearing open item isn't the jury verdict alone — it's the remedy: "Qualcomm wants Judge Maryellen Noreika to rule that a clause in its contracts lets it stop paying Arm royalties for five years if a breach is proven. She hasn't ruled yet."
The asymmetry is the trade. TIKR runs the numbers from Arm's own annual filing: "Qualcomm accounted for 9% of its $4.92 billion revenue in the fiscal year ended March 31, 2026, or approximately $443 million... Arm's operating income was $908 million last fiscal year, so Qualcomm's payments equal about 49% of it. Qualcomm earned $10.43 billion in operating income over the last twelve months (LTM), which puts the same payments at about 4%." If Noreika upholds the five-year clause and the jury finds breach, Qualcomm could stop paying royalties for five years to a supplier that counts it as ~half its operating profit1. Without the clause, a breach finding only opens an ordinary damages claim Qualcomm would still have to quantify.
The second-order fight is the next license. Arm's lawyer pressed CEO Cristiano Amon on a 2013 deal that "caps royalties at $1.88 per chip for any chip with at least five CPU cores, a price set long before data center chips carried 288 cores" (TIKR). A breach finding would weaken Arm's hand in next-architecture negotiations — which matters well beyond this case, because it prices what Arm can charge for the AI-era CPU cores at the center of its data-center growth story.
Market position going into the verdict: QCOM closed at $175.50 Friday, down 5.1% over five days, RSI 31, 29.4% below its 52-week high — still above the $161.26 Amazon warrant strike (that watch stays open), and still above its 50- and 200-day moving averages. ARM Holdings ADR closed at $266.28, -3.27% on the day. The stock with more at risk on a Qualcomm win is unambiguously ARM: ~$2.2B of five-year revenue at stake against $908M of annual operating income.
-
An instance of When AI chip demand is assured, the fight moves to who keeps the margin. — The contest is over the contractual terms of payment on demand nobody doubts, with a single remedy clause capable of zeroing half a supplier's operating income. ↩︎